NRAS and melanoma: Importantly, this striking effect on SOX10 protein levels was present in all melanoma cultures, irrespective of whether they harbor activating BRAF p.V600E, NRAS p.Q61K, or both mutations, and irrespective of whether they are sensitive to MAPK inhibition or resistant (Supplementary Fig. S1a).